同型半胱氨酸在肝纤维化和肝硬化发展中的作用

王亚刚; 胡国信

doi:10.3969/j.issn.1001-5256.2020.05.044

同型半胱氨酸在肝纤维化和肝硬化发展中的作用

DOI: 10.3969/j.issn.1001-5256.2020.05.044

1. 广州医科大学
2. 北京大学深圳医院感染病科
3. 深圳市福田区慢性病防治院

详细信息

中图分类号: R575.2
计量
- 文章访问数: 825
- HTML全文浏览量: 54
- PDF下载量: 132
- 被引次数: 0
出版历程
- 出版日期: 2020-05-20

Mechanism of action of homocysteine in the development of liver fibrosis and liver cirrhosis

Guangzhou Medical University, Guangzhou 510006, China

摘要

摘要:
同型半胱氨酸(Hcy)因被发现与心脑血管病、高血压、糖尿病、肾脏病变、骨骼系统疾病甚至精神疾病具有明显相关性而被医学界所关注。近年来,Hcy在肝纤维化、肝硬化中的应用也越来越被临床医生及研究者所重视。综述了近年来国内外有关Hcy的代谢机制、生理病理意义,并着重阐述了Hcy和肝纤维化、肝硬化的相关性和可能机制。
- 高半胱氨酸 /
- 肝硬化 /
- 高血糖症 /
- 氧化应激
Abstract:
Homocysteine(Hcy) has attracted more and more attention in the medical field since it was found to be closely associated with cardiovascular and cerebrovascular diseases, hypertension, diabetes, kidney diseases, skeletal system diseases, and even mental illnesses.In recent years, the application of Hcy in patients with liver fibrosis and liver cirrhosis has been taken more seriously by clinicians and researchers. This article reviews the recent research advances in the metabolic mechanism and pathophysiologic significance of Hcy in China and foreign countries and highlights the association of Hcy with liver fibrosis and liver cirrhosis and its possible mechanism.
- homocysteine /
- liver fibrosis /
- hyperglycemia /
- oxidative stress

HTML全文

参考文献(34)

[1] de REZENDE MM, D’ ALMEIDA V. Central and systemic responses to methionine-induced hyperhomocysteinemia in mice[J]. PLoS One, 2014, 9(8):e105704.

[2] LOW HQ, CHEN CP, KASIMAN K, et al. A comprehensive association analysis of homocysteine metabolic pathway genes in Singaporean Chinese with ischemic stroke[J]. PLoS One,2011, 6(9):e24757.

[3] BOSY-WESTPHAL A, PETERSEN S, HINRICHSEN H, et al.Increased plasma homocysteine in liver cirrhosis[J]. Hepatol Res, 2001, 20(1):28-38.

[4] MEDICI V, PEERSON JM, STABLER SP, et al. Impaired homoc-ysteine transsulfuration is an indicator of alcoholic liver disease[J]. J Hepatol, 2010, 53(3):551-557.

[5] ZEMLIANITSYNA O, POLOZOVA L, KARACHENTSEV I, et al.Features of excretion of melatonin in urine in patients with type2 diabetes mellitus and non-alcoholic fatty liver disease with anifestations of fibrosis and its relationship with certain metabolic and immunological indicators[J]. Georgian Med News,2018, 274:103-107.

[6] HU Y, LIU J, DONG X, et al. Clinical study of serum homocysteine and non-alcoholic fatty liver disease in euglycemic patients[J]. Med Sci Monit, 2016, 22:4146-4151.

[7] SHEN XW, SUN GH, SUN GZ, et al. Assessment of homocysteine concentration in chronic hepatic injury[J]. Chin J Hepatol, 2003, 11(4):242.(in Chinese）沈雄文，孙国红，孙关忠，等．肝损伤时血清同型半胱氨酸的浓度变化[J]．中华肝脏病杂志，2003, 11(4):242.

[8] McCULLY KS. vascular pathology of homocysteinemia:Implications for the pathogenesis of arteriosclerosis[J]. Am J Pathol, 1969, 56(1):111-128.

[9] STAMLER JS, OSBORNE JA, JARAKI O, et al. Adverse vascular effects of homocysteine are modulated by endotheliumderived relaxing factor and related oxides of nitrogen[J]. J Clin Invest, 1993, 91(1):308-318.

[10] STAMLER JS, JIA L, EU JP, et al. Blood flow regulation by Snitrosohemoglobin in the physiological oxygen gradient[J].Science, 1997, 276(5321):2034-2037.

[11] van der GRAAFF D, KWANTEN WJ, FRANCQUE SM. The potential role of vascular alterations and subsequent impaired liver blood flow and hepatic hypoxia in the pathophysiology of non-alcoholic steatohepatitis[J]. Med Hypotheses, 2019,122:188-197.

[12] TUNG HC, HSU SJ, TSAI MH, et al. Homocysteine deteriorates intrahepatic derangement and portal-systemic col aterals in cirrhotic rats[J]. Clin Sci(Lond), 2017, 131(1):69-86.

[13] KORKMAZ S, YILMAZ A, YILDIZ G, et al. Relationship between homocysteine and non-dipper pattern in patients with type 2 diabetes mellitus[J]. Arq Bras Endocrinol Metabol,2012, 56(5):285-290.

[14] ZHAO J, QI YF, YU YR. Research advances in the role of oxidative stress in the development and progression of liver fibrosis[J]. J Clin Hepatol, 2019, 35(9):2067-2071.(in Chinese）赵杰，齐永芬，鱼艳荣．氧化应激在肝纤维化发生发展中的作用[J]．临床肝胆病杂志，2019, 35(9):2067-2071.

[15] KUMAR M, SANDHIR R. Neuroprotective effect of hydrogen sulfide in hyperhomocysteinemia is mediated through antioxidant action involving Nrf2[J]. Neuromolecular Med, 2018, 20(4):475-490.

[16] GUPTA M, SHARMA P, GARG G, et al. Plasma homocysteine:An independent or an interactive risk factor for coronary artery disease[J]. Clin Chim Acta, 2005, 352(1-2):121-125.

[17] WILSON KM, LENTZ SR. Mechanisms of the atherogenic effects of elevated homocysteine in experimental models[J]. SeminVascMed, 2005, 5(2):163-171.

[18] GUTHIKONDA S, HAYNES WG. Homocysteine:Role and implications in atherosclerosis[J]. Curr Atheroscler Rep, 2006,8(2):100-106.

[19] LOSCALZO J. The oxidant stress of hyperhomocyst(e)inemia[J]. J Clin Invest, 1996, 98(1):5-7.

[20] MOHAMMADIAN Z, EIDI A, MORTAZAVI P, et al. Effects of folic acid on dyslipidemia and serum homocysteine in a rat model of cholestasis and hepatic fibrosis[J]. Pol J Pathol,2015, 66(1):49-56.

[21] EL-MISSIRY MA, OTHMAN AI, EL-SAWY MR, et al. Neuroprotective effect of epigallocatechin-3-gallate(EGCG)on radiation-induced damage and apoptosis in the rat hippocampus[J]. Int J Radiat Biol, 2018, 94(9):798-808.

[22] FORD TC, DOWNEY LA, SIMPSON T, et al. The effect of a high-dose vitamin B multivitamin supplement on the relationship between brain metabolism and blood biomarkers of oxidative stress:A randomized control trial[J]. Nutrients, 2018, 10(12):e1860.

[23] STANGER O, WEGER M. Interactions of homocysteine, nitric oxide, folate and radicals in the progressively damaged endothelium[J]. Clin Chem Lab Med, 2003, 41(11):1444-1454.

[24] LI Y, JIANG C, XU G, et al. Homocysteine upregulates resistin production from adipocytes in vivo and in vitro[J]. Diabetes, 2008, 57(4):817-827.

[25] LI J, XUE YM, PAN YH, et al. The role of Hepatic insulin resistance in the pathogenesis of spontaneously diabetic OLETF rats[J]. China Med Herald, 2018, 15(14):12-16.(in Chinese）李佳，薛耀明，潘永华，等．肝脏胰岛素抵抗在自发性糖尿病OLETF大鼠发病中的作用[J]．中国医药导报，2018, 15(14):12-16.

[26] GUO YY, CHUN H, LUO QQ, et al. Dynamic fluctuation of blood glucose and its effects on prognosis in patients with nonalcoholic fatty liver disease complicated with type 2 diabetes mellitus[J]. J Clin Exp Med, 2019, 18(11):1173-1175.(in Chinese）郭郁郁，春华，罗清琼，等．非酒精性脂肪性肝病合并2型糖尿病患者血糖动态波动水平及其对预后的影响[J]．临床和实验医学杂志，2019, 18(11):1173-1175.

[27] FANG S,CAI YY, LI P, et al. Exendin-4 alleviates oxidative stress and liver fibrosis by activating Nrf2/HO-1 in streptozotocin-induced diabetic mice[J]. J South Med Univ, 2019,39(4):464-470.(in Chinese）方舒，蔡迎迎，李萍，等．Exendin-4通过激活Nrf2/HO-1通路减轻糖尿病小鼠的肝脏氧化应激及纤维化[J]．南方医科大学学报，2019, 39(4):464-470.

[28] SPADARO L, PRIVITERA G, FEDE G, et al. Diabetes increases renovascular impedance in patients with liver cirrhosis[J].Intern Emerg Med, 2015, 10(6):703-709.

[29] MUDALIAR S, HENRY RR, CIARALDI TP, et al. Reduced peripheral activity leading to hepato-preferential action of basal insulin peglispro compared with insulin glargine in patients with type 1 diabetes[J]. Diabetes Obes Metab, 2016, 18(Suppl2):17-24.

[30] LI SJ, LIU H, LIU JM, et al. Effects of fluctuant high blood glucose on hepatic function and ultrastructure in diabetic rats[J]. J Hepatopancreatobiliary Surg, 2011, 23(1):7-10.(in Chinese）李素娟，刘浩，李剑敏，等．糖尿病大鼠血糖波动对肝脏功能及超微结构的影响[J]．肝胆胰外科杂志，2011, 23(1):7-10.

[31] PANG Y, KARTSONAKI C, TURNBULL I, et al. Diabetes,plasma glucose, and incidence of fatty liver, cirrhosis, and liver cancer:A prospective study of 0. 5 million people[J].Hepatology, 2018, 68(4):1308-1318.

[32] TUNG HC, HSU SJ, TSAI MH, et al. Homocysteine deteriorates intrahepatic derangement and portal-systemic col aterals in cirrhotic rats[J]. Clin Sci(Lond), 2017, 131(1):69-86.

[33] LI SX, LI LH, DANG XW. Research advances in the role of coagulation factors in liver fibrosis[J]. J Clin Hepatol, 2018, 34(7):1547-1550.(in chinese）李素新，李璐豪，党晓卫．凝血因素在肝纤维化发生发展中的作用[J]．临床肝胆病杂志，2018, 34(7):1547-1550.

[34] MEDICI V, PEERSON JM, STABLER SP, et al. Impaired homocysteine transsulfuration is an indicator of alcoholic liver disease[J]. J Hepatol, 2010, 53(3):551-557.

施引文献

资源附件(0)

访问统计